Abstract
Precise remote control of skeletal muscle contraction could be beneficial to the study and treatment of muscular dysfunction. Recently, we reported a method regulating intracellular calcium signaling using molecular motors (MMs), molecules that rotate sub-molecular components unidirectionally upon absorption of light. Here, we explore the application of this methodology to skeletal muscle tissue. Our results demonstrate that MMs induce intracellular calcium release in C2C12 myoblasts and differentiated myotubes via IP3-mediated signaling in a fashion that depends on their fast unidirectional rotation. Inhibition of proteins involved in the cAMP pathway such as adenylyl cyclase and protein kinase A also reduced the magnitude of the elicited calcium responses. We further show that, in differentiated C2C12 myotubes, the calcium signaling events driven by MM activation cause localized myotube contraction. This work demonstrates the use of a molecular mechanical technique to directly control skeletal muscle contraction, expanding the scope of available tools to study muscle contraction in a single-cell regime and treat a range of myopathies.
Supplementary materials
Title
Supporting Information Molecular Motors Activate Skeletal Muscle
Description
Figure S1–17
Actions
Title
video 1
Description
Supplementary Video 1: Localized calcium responses in C2C12 myotubes treated with MM 1 (8 µM) and 400-nm light for 1.5s.
Actions
Title
Video 2
Description
Supplementary Video 2: Brightfield of C2C12 myotubes treated with MM 1 (8 µM) and 400-nm light for 1.5s.
Actions
Title
Video 3
Description
Supplementary Video 3: Brightfield after image subtraction method of C2C12 myotubes treated with MM 1 (8 µM) and 400-nm light for 1.5s.
Actions
Title
Video 4
Description
Supplementary Video 4: Localized calcium responses in C2C12 myotubes treated with DMSO and 400-nm light for 1.5s.
Actions
Title
Video 5
Description
Supplementary Video 5: Brightfield of C2C12 myotubes treated with DMSO and 400-nm light for 1.5s.
Actions
Title
Video 6
Description
Supplementary Video 6: Brightfield after image subtraction method of C2C12 myotubes treated with DMSO and 400-nm light for 1.5s.
Actions
Title
Video 7
Description
Supplementary Video 7: Localized calcium responses in C2C12 myotubes treated with MM 2 (8 µM) and 400-nm light for 1.5s.
Actions
Title
Video 8
Description
Supplementary Video 8: Brightfield of C2C12 myotubes treated with MM 2 (8 µM) and 400-nm light for 1.5s.
Actions
Title
Video 9
Description
Supplementary Video 9: Brightfield after image subtraction method of C2C12 myotubes treated with MM 2 (8 µM) and 400-nm light for 1.5s.
Actions
Title
Video 10
Description
Supplementary Video 10: Localized calcium responses in C2C12 myotubes treated with MM 3 (8 µM) and 400-nm light for 1.5s.
Actions
Title
Video 11
Description
Supplementary Video 11: Brightfield of C2C12 myotubes treated with MM 3 (8 µM) and 400-nm light for 1.5s.
Actions
Title
Video 12
Description
Supplementary Video 12: Brightfield after image subtraction method of C2C12 myotubes treated with MM 3 (8 µM) and 400-nm light for 1.5s.
Actions
Title
Video 13
Description
Supplementary Video 13: Localized calcium responses in C2C12 myotubes treated with MM 1 (8 µM) and U73 (10 µM) and 400-nm light for 1.5s.
Actions
Title
Video 14
Description
Supplementary Video 14: Brightfield of C2C12 myotubes treated with MM 1 (8 µM) and U73 (10 µM) and 400-nm light for 1.5s.
Actions
Title
Video 15
Description
Supplementary Video 15: Brightfield after image subtraction method of C2C12 myotubes treated with MM 1 (8 µM) and U73 (10 µM) and 400-nm light for 1.5s.
Actions